Page 3 - Best Radiotherapy doctors: TOP 97 doctors

Specializing in pediatric hematology and oncology – Sema Anak focuses on children's cancer care at Medipol Mega University Hospital.

• Expert in pediatric oncology treatments
• Works at a leading university hospital
• Dedicated to children's cancer care

Dr. Bunyamin Kaplan is a dedicated radiation oncologist at Medipol Mega University Hospital, focusing on precise and effective radiotherapy treatments.

• Specializes in advanced radiotherapy techniques
• Works at a leading university hospital
• Committed to personalized patient care

Associate Professor since 2016, Dr. Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye University Liv Hospital Bahcesehir.

• Internal Medicine Specialist with experience in top Turkish hospitals
• Experienced in treating complex oncology cases across multiple cancer types
• Member of Turkish oncology associations with progressive academic achievements

Dr. Gal Goldstein, recognized in Forbes' best doctors list, heads the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.

• Over 27 years of experience of specialization in pediatric hemato-oncology and haploidentical bone marrow transplantation
• Member of multiple prestigious oncology associations including SIOP and ISPHO
• Focuses on retinoblastoma and precision medicine in pediatric oncology

Dr. Alon Pikarsky brings over 39 years of experience of surgical expertise, specializing in colorectal surgery at Hadassah Medical Center.

• Instructor in Surgery since 1995, training future surgeons
• Director of Medical Students Program since 1997
• Israel Board Certified in General Surgery since 1998
• Member of various surgical associations since 1998

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center, with 36 years of experience of specialized experience in oncology and radiotherapy.

• Specializes in Medical Oncology & Radiotherapy
• Senior physician at Hadassah University Hospital
• Certified in Oncology & Radiotherapy
• Member of Israel Society of Clinical Oncology

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Prof. Myriam Ben Arush is an internationally recognized specialist in pediatric oncology and bone marrow transplantation at Ruth Rappaport Children’s Hospital.

• Director of Pediatric Division at Rambam Medical Center
• Recipient of the Chevalier de la Legion d’Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of children’s oncology group in the USA and European cancer societies

Specializes in head and neck tumors and thyroid cancer with advanced radiotherapy techniques at Hadassah Medical Center.

• Trained in radiosurgery at Memorial Sloan Kettering Cancer Center
• Over 23 years of experience of experience in oncology and radiotherapy
• Former Head of Head and Neck Oncology Division at Davidoff Cancer Center
• Director of Oncology Department at Hadassah since 2019

Dr. Pfeffer specializes in oncology and radiology at Assuta Medical Center, offering targeted radiotherapy treatments.

• Dual expertise in oncology and radiology for comprehensive care
• Practices at Assuta Medical Center – a leading facility in Israel
• Focuses on personalized radiotherapy plans for each patient

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Zalmanova specializes in radiotherapy at Assuta Medical Center, providing targeted cancer treatments.

• Focuses on delivering precise radiation therapy
• Works with advanced radiotherapy technology
• Part of a renowned oncology team at Assuta

Head of Oncology at Quironsalud Madrid – Dr. González Cortijo specializes in breast and gynecologic cancers with 20+ years of experience.

• Expert in precision oncology and targeted therapies
• Principal investigator in over 20 clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Founder of 'La Vida en Rosa Foundation' for cancer support
• Member of ESMO and ASCO

Prof. Ben Boursi specializes in gastrointestinal oncology and radiotherapy, with groundbreaking research on microbiome's role in cancer treatment at Sheba Medical Center.

• Trained in gastrointestinal oncology at University of Pennsylvania
• Founder of ECOG-ACRIN Microbiome Working Group
• Published in top journals like Science
• Develops predictive models for early cancer detection
• Board-certified in internal medicine and medical oncology

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.